Patient characteristics, treatment patterns, and outcomes of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer patients prescribed cyclin-dependent kinase 4 and 6 inhibitors: large-scale data analysis using a Japanese claims database.
Masaaki KawaiMasahiro TakadaTakahiro NakayamaNorikazu MasudaHirokazu ShiheidoZhihong CaiYu-Jing HuangTsutomu KawaguchiYoshinori TanizawaPublished in: Breast cancer research and treatment (2022)
The data provide insights into current clinical practices for CDK4 and 6 inhibitor use in Japan that could help establish future treatment strategies for ABC.
Keyphrases
- data analysis
- epidermal growth factor receptor
- tyrosine kinase
- cell cycle
- advanced non small cell lung cancer
- endothelial cells
- healthcare
- primary care
- case report
- health insurance
- current status
- induced pluripotent stem cells
- metabolic syndrome
- emergency department
- pluripotent stem cells
- weight loss
- deep learning
- cell proliferation
- adverse drug
- cell death
- glycemic control